National Institutes of Health and the National Institute on Drug Abuse awarded a $19 million grant to advance the molecule SBS-518 into a human clinical trial.
Dr. McCurdy assumed the new leadership position on May 1.
UF Health honored 33 endowed professors and chairs across the six academic colleges at a special Celebrating Distinction ceremony on Oct. 13.
The course was developed by the UF/IFAS College of Agricultural and Life Sciences and the UF College of Pharmacy.
McCurdy began researching kratom in 2005 and the study represents the first time his team’s kratom research has appeared on a journal cover.
UF researchers found kratom delivered significant pain-relieving benefits, reduced opioid withdrawal symptoms and caused minimal respiratory depression.
The grant will bolster research on Mitragyna speciosia, or kratom, and its potential to treat opioid misuse and physical dependence.
Medicinal chemistry professor Christopher McCurdy, Ph.D., was installed as the 2018 American Association of Pharmaceutical Scientists, or AAPS, president at the organization's annual meeting Nov. 12-15 in San Diego.
McCurdy, Ph.D., a professor of medicinal chemistry, was interviewed by CNN about kratom and its potential to treat pain and opioid withdrawal.